Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.29
STE's Cash to Debt is ranked lower than
78% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. STE: 0.29 )
Ranked among companies with meaningful Cash to Debt only.
STE' s 10-Year Cash to Debt Range
Min: 0.04  Med: 0.32 Max: No Debt
Current: 0.29
Equity to Asset 0.50
STE's Equity to Asset is ranked lower than
64% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. STE: 0.50 )
Ranked among companies with meaningful Equity to Asset only.
STE' s 10-Year Equity to Asset Range
Min: 0.43  Med: 0.57 Max: 0.85
Current: 0.5
0.43
0.85
Interest Coverage 11.84
STE's Interest Coverage is ranked lower than
69% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. STE: 11.84 )
Ranked among companies with meaningful Interest Coverage only.
STE' s 10-Year Interest Coverage Range
Min: 1.31  Med: 16.05 Max: 76.18
Current: 11.84
1.31
76.18
F-Score: 5
Z-Score: 4.38
M-Score: -2.74
WACC vs ROIC
10.52%
9.50%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.10
STE's Operating margin (%) is ranked higher than
64% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. STE: 12.10 )
Ranked among companies with meaningful Operating margin (%) only.
STE' s 10-Year Operating margin (%) Range
Min: 3.02  Med: 12.85 Max: 17.1
Current: 12.1
3.02
17.1
Net-margin (%) 7.18
STE's Net-margin (%) is ranked higher than
62% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. STE: 7.18 )
Ranked among companies with meaningful Net-margin (%) only.
STE' s 10-Year Net-margin (%) Range
Min: -5.2  Med: 7.79 Max: 10.65
Current: 7.18
-5.2
10.65
ROE (%) 12.55
STE's ROE (%) is ranked higher than
72% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. STE: 12.55 )
Ranked among companies with meaningful ROE (%) only.
STE' s 10-Year ROE (%) Range
Min: -10.22  Med: 12.80 Max: 21.36
Current: 12.55
-10.22
21.36
ROA (%) 6.49
STE's ROA (%) is ranked higher than
69% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. STE: 6.49 )
Ranked among companies with meaningful ROA (%) only.
STE' s 10-Year ROA (%) Range
Min: -5.41  Med: 7.10 Max: 10.62
Current: 6.49
-5.41
10.62
ROC (Joel Greenblatt) (%) 29.88
STE's ROC (Joel Greenblatt) (%) is ranked higher than
75% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. STE: 29.88 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1.79  Med: 24.66 Max: 38.9
Current: 29.88
-1.79
38.9
Revenue Growth (3Y)(%) 8.90
STE's Revenue Growth (3Y)(%) is ranked higher than
70% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. STE: 8.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STE' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.6  Med: 7.20 Max: 13.4
Current: 8.9
0.6
13.4
EBITDA Growth (3Y)(%) 3.10
STE's EBITDA Growth (3Y)(%) is ranked lower than
61% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. STE: 3.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -18.3  Med: 6.90 Max: 67.8
Current: 3.1
-18.3
67.8
EPS Growth (3Y)(%) -0.90
STE's EPS Growth (3Y)(%) is ranked lower than
63% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. STE: -0.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STE' s 10-Year EPS Growth (3Y)(%) Range
Min: -72.2  Med: 7.75 Max: 293.6
Current: -0.9
-72.2
293.6
» STE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

STE Guru Trades in Q3 2014

RS Investment Management 525,120 sh (New)
Jim Simons 57,600 sh (+81.13%)
Ken Fisher 1,607,171 sh (+1.29%)
Mario Gabelli 113,000 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 1,136,941 sh (-1.93%)
Paul Tudor Jones 11,700 sh (-25.95%)
» More
Q4 2014

STE Guru Trades in Q4 2014

Joel Greenblatt 5,127 sh (New)
Jeremy Grantham 20,200 sh (New)
Paul Tudor Jones 18,500 sh (+58.12%)
RS Investment Management 826,038 sh (+57.30%)
Ken Fisher 1,628,706 sh (+1.34%)
Mario Gabelli 113,000 sh (unchged)
Jim Simons Sold Out
Chuck Royce 987,041 sh (-13.18%)
» More
Q1 2015

STE Guru Trades in Q1 2015

RS Investment Management 947,974 sh (+14.76%)
Joel Greenblatt Sold Out
Ken Fisher 1,624,591 sh (-0.25%)
Mario Gabelli 111,000 sh (-1.77%)
Jeremy Grantham 18,800 sh (-6.93%)
Chuck Royce 902,541 sh (-8.56%)
Paul Tudor Jones 10,600 sh (-42.70%)
» More
Q2 2015

STE Guru Trades in Q2 2015

Joel Greenblatt 495,801 sh (New)
Jim Simons 214,700 sh (New)
Paul Tudor Jones 21,885 sh (+106.46%)
RS Investment Management 1,069,123 sh (+12.78%)
RS Investment Management 1,069,123 sh (+12.78%)
Mario Gabelli 111,000 sh (unchged)
Ken Fisher 1,613,251 sh (-0.70%)
Chuck Royce 801,841 sh (-11.16%)
Jeremy Grantham 7,900 sh (-57.98%)
» More
» Details

Insider Trades

Latest Guru Trades with STE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.55
STE's P/E(ttm) is ranked higher than
52% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. STE: 28.55 )
Ranked among companies with meaningful P/E(ttm) only.
STE' s 10-Year P/E(ttm) Range
Min: 11.06  Med: 20.54 Max: 54.91
Current: 28.55
11.06
54.91
Forward P/E 23.42
STE's Forward P/E is ranked lower than
63% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. STE: 23.42 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.90
STE's PE(NRI) is ranked lower than
53% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. STE: 28.90 )
Ranked among companies with meaningful PE(NRI) only.
STE' s 10-Year PE(NRI) Range
Min: 11.08  Med: 21.06 Max: 54.83
Current: 28.9
11.08
54.83
P/B 3.49
STE's P/B is ranked lower than
57% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. STE: 3.49 )
Ranked among companies with meaningful P/B only.
STE' s 10-Year P/B Range
Min: 1.68  Med: 2.37 Max: 3.94
Current: 3.49
1.68
3.94
P/S 2.05
STE's P/S is ranked higher than
57% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. STE: 2.05 )
Ranked among companies with meaningful P/S only.
STE' s 10-Year P/S Range
Min: 0.94  Med: 1.54 Max: 2.3
Current: 2.05
0.94
2.3
PFCF 24.69
STE's PFCF is ranked higher than
66% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. STE: 24.69 )
Ranked among companies with meaningful PFCF only.
STE' s 10-Year PFCF Range
Min: 8.72  Med: 20.66 Max: 114.75
Current: 24.69
8.72
114.75
POCF 15.98
STE's POCF is ranked higher than
58% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. STE: 15.98 )
Ranked among companies with meaningful POCF only.
STE' s 10-Year POCF Range
Min: 7.09  Med: 12.36 Max: 22.12
Current: 15.98
7.09
22.12
EV-to-EBIT 18.95
STE's EV-to-EBIT is ranked higher than
54% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. STE: 18.95 )
Ranked among companies with meaningful EV-to-EBIT only.
STE' s 10-Year EV-to-EBIT Range
Min: 7.2  Med: 11.65 Max: 29
Current: 18.95
7.2
29
PEG 3.04
STE's PEG is ranked lower than
56% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. STE: 3.04 )
Ranked among companies with meaningful PEG only.
STE' s 10-Year PEG Range
Min: 0.53  Med: 2.10 Max: 22.76
Current: 3.04
0.53
22.76
Shiller P/E 29.63
STE's Shiller P/E is ranked higher than
51% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. STE: 29.63 )
Ranked among companies with meaningful Shiller P/E only.
STE' s 10-Year Shiller P/E Range
Min: 14.83  Med: 23.09 Max: 34.83
Current: 29.63
14.83
34.83
Current Ratio 2.79
STE's Current Ratio is ranked higher than
62% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. STE: 2.79 )
Ranked among companies with meaningful Current Ratio only.
STE' s 10-Year Current Ratio Range
Min: 1.49  Med: 2.36 Max: 4.91
Current: 2.79
1.49
4.91
Quick Ratio 2.09
STE's Quick Ratio is ranked higher than
64% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. STE: 2.09 )
Ranked among companies with meaningful Quick Ratio only.
STE' s 10-Year Quick Ratio Range
Min: 1.18  Med: 1.69 Max: 4.49
Current: 2.09
1.18
4.49
Days Inventory 59.79
STE's Days Inventory is ranked higher than
85% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. STE: 59.79 )
Ranked among companies with meaningful Days Inventory only.
STE' s 10-Year Days Inventory Range
Min: 53.59  Med: 64.35 Max: 93.17
Current: 59.79
53.59
93.17
Days Sales Outstanding 56.65
STE's Days Sales Outstanding is ranked higher than
59% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. STE: 56.65 )
Ranked among companies with meaningful Days Sales Outstanding only.
STE' s 10-Year Days Sales Outstanding Range
Min: 62.38  Med: 80.89 Max: 105.39
Current: 56.65
62.38
105.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.47
STE's Dividend Yield is ranked higher than
51% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. STE: 1.47 )
Ranked among companies with meaningful Dividend Yield only.
STE' s 10-Year Dividend Yield Range
Min: 0.15  Med: 1.36 Max: 2.34
Current: 1.47
0.15
2.34
Dividend Payout 0.41
STE's Dividend Payout is ranked lower than
59% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. STE: 0.41 )
Ranked among companies with meaningful Dividend Payout only.
STE' s 10-Year Dividend Payout Range
Min: 0.1  Med: 0.25 Max: 0.58
Current: 0.41
0.1
0.58
Dividend growth (3y) 10.90
STE's Dividend growth (3y) is ranked higher than
57% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. STE: 10.90 )
Ranked among companies with meaningful Dividend growth (3y) only.
STE' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 34.7
Current: 10.9
0
34.7
Yield on cost (5-Year) 2.91
STE's Yield on cost (5-Year) is ranked higher than
73% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. STE: 2.91 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STE' s 10-Year Yield on cost (5-Year) Range
Min: 0.3  Med: 2.71 Max: 4.67
Current: 2.91
0.3
4.67
Share Buyback Rate -0.60
STE's Share Buyback Rate is ranked higher than
66% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. STE: -0.60 )
Ranked among companies with meaningful Share Buyback Rate only.
STE' s 10-Year Share Buyback Rate Range
Min: 4.8  Med: 0.30 Max: -2.5
Current: -0.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 21.77
STE's Price/Tangible Book is ranked lower than
90% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. STE: 21.77 )
Ranked among companies with meaningful Price/Tangible Book only.
STE' s 10-Year Price/Tangible Book Range
Min: 2.69  Med: 4.54 Max: 21.84
Current: 21.77
2.69
21.84
Price/Projected FCF 1.75
STE's Price/Projected FCF is ranked lower than
51% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. STE: 1.75 )
Ranked among companies with meaningful Price/Projected FCF only.
STE' s 10-Year Price/Projected FCF Range
Min: 0.82  Med: 1.41 Max: 14.78
Current: 1.75
0.82
14.78
Price/DCF (Earnings Based) 2.08
STE's Price/DCF (Earnings Based) is ranked lower than
53% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.72 vs. STE: 2.08 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.34
STE's Price/Median PS Value is ranked lower than
64% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. STE: 1.34 )
Ranked among companies with meaningful Price/Median PS Value only.
STE' s 10-Year Price/Median PS Value Range
Min: 0.55  Med: 1.04 Max: 2.83
Current: 1.34
0.55
2.83
Price/Peter Lynch Fair Value 1.99
STE's Price/Peter Lynch Fair Value is ranked higher than
50% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. STE: 1.99 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
STE' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.45  Med: 1.86 Max: 41.83
Current: 1.99
0.45
41.83
Price/Graham Number 5.25
STE's Price/Graham Number is ranked lower than
82% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. STE: 5.25 )
Ranked among companies with meaningful Price/Graham Number only.
STE' s 10-Year Price/Graham Number Range
Min: 1.17  Med: 2.21 Max: 11.56
Current: 5.25
1.17
11.56
Earnings Yield (Greenblatt) (%) 5.31
STE's Earnings Yield (Greenblatt) (%) is ranked higher than
70% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. STE: 5.31 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STE' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.4  Med: 8.55 Max: 13.9
Current: 5.31
3.4
13.9
Forward Rate of Return (Yacktman) (%) 17.31
STE's Forward Rate of Return (Yacktman) (%) is ranked higher than
68% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. STE: 17.31 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STE' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 6.2  Med: 13.60 Max: 39.2
Current: 17.31
6.2
39.2

Analyst Estimate

Mar16 Mar17
Revenue(Mil) 1,978 2,117
EPS($) 2.74 3.67
EPS without NRI($) 2.74 3.67

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:STQ.Germany,
Steris Corp was founded as Innovative Medical Technologies in Ohio in 1985, and renamed STERIS Corporation in 1987. The Company is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research. It offers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room ('OR') integration; consumable products, such as detergents and skin care products, gastrointestinal ('GI') endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in three business segments: Healthcare, Life Sciences, and Isomedix. Healthcare segment manufactures and sells capital equipment, accessory, consumable, and service solutions to healthcare providers, including acute care hospitals, surgery and gastrointestinal centers. Brand names for these products include SYSTEM 1E, Amsco, Hamo, Reliance, Cmax, Harmony, Kindest Kare, Alcare, Verify, Cal Stat, Roth Net, Little Sister, and T-Series. Life Sciences segment manufactures and sells capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies, and private and public research facilities. Brand names for these products include Amsco, Reliance, Finn-Aqua, VHP, and the CIP Products.Isomedix segment sells comprehensive array of contract sterilization services using gamma irradiation and ethylene oxide ("EO") technologies as well as an array of laboratory testing services. Its competitors include 3M, Belimed, Cantel Medical, Ecolab, Getinge, Go Jo, Johnson & Johnson, Kimberly-Clark, Skytron, and Stryker. The Company is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and in other countries.
» More Articles for STE

Headlines

Articles On GuruFocus.com
16 Best Dividend Paying Healthcare Stocks Sep 03 2012 
Supply Your Portfolio with Healthy Growth from Medical Suppliers May 25 2012 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2011 
STERIS Corp. Reports Operating Results (10-Q) Nov 09 2010 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 11,600 Shares Oct 01 2010 
STERIS Corp. (STE) SVP & CFO Michael J Tokich sells 9,000 Shares Apr 09 2010 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2010 
Robert Olstein on Hedge Fund regulations. Recent Olstein buys. Jan 15 2010 
STERIS Corp. Reports Operating Results (10-Q) Nov 03 2009 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 5,000 Shares Oct 02 2009 

More From Other Websites
Form 8.3 - Steris Corporation Sep 04 2015
MEDIA-U.S. FTC accuses Synergy Health of "killing" U.S. expansion plan-Times Sep 03 2015
STERIS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Aug 31 2015
Form 8.3 - Steris Corporation Aug 28 2015
Form 8.3 - Steris Corporation Aug 25 2015
Form 8.3 - Steris Corporation Aug 24 2015
Form 8.3 - Steris Corporation Aug 21 2015
STERIS CORP Financials Aug 20 2015
Form 8.3 - STERIS Corp Aug 20 2015
Form 8.3 - Steris Corporation Aug 18 2015
Form 8.3 - Steris Corporation Aug 14 2015
Form 8.3 - Steris Corporation Aug 13 2015
Form 8.3 - Steris Corporation Aug 12 2015
Form 8.3 - Steris Corporation Aug 11 2015
10-Q for STERIS Corp. Aug 10 2015
Form 8.3 - Steris Corporation Aug 10 2015
STERIS CORP Files SEC form 10-Q, Quarterly Report Aug 07 2015
Form 8.3 - Steris Corporation Aug 07 2015
Form 8.3 - Steris Corporation Aug 06 2015
STERIS Q1 Earnings Beat, Rise Y/Y; Revenue Guidance Raised - Analyst Blog Aug 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK